Lupus & Connective Tissue Diseases
Conference Coverage
First validated classification criteria for discoid lupus erythematosus unveiled
“The point is to be able to differentiate between discoid lupus and its disease mimickers, which could be confused in enrollment in clinical...
Conference Coverage
ACIP approves flu vaccine recommendations for 2020-2021
Next season’s vaccination options include new high-dose quadrivalent vaccines for seniors.
Conference Coverage
In scleroderma, GERD questionnaires are essential tools
“The questionnaires are really critical for us to grade the severity and then properly order tests,” said Dr. Tracy M. Frech.
Conference Coverage
Belimumab safely improved renal function in lupus nephritis patients
Adding belimumab to standard SLE treatment led to better renal function after 2 years in a multicenter, randomized, controlled trial with 446...
Conference Coverage
Antinuclear antibody test interpretation guidance gets updated
Clinicians should be aware of the type of assay used for antinuclear antibody detection because the results can vary by disease.
Conference Coverage
Be vigilant for scleroderma renal crisis
Thirty percent of patients with scleroderma renal crisis present atypically.
Conference Coverage
EULAR’s COVID-19 recommendations offer no surprises
The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and...
Conference Coverage
Age leads COVID-19 hospitalization risk factors in RMDs
Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in...
Conference Coverage
Most rheumatology drugs don’t increase COVID-19 hospitalization risk
“These results provide, for the first time, information about the outcome of COVID-19 in patients with rheumatic and musculoskeletal diseases.”
Conference Coverage
Avacopan notches a win in ANCA-associated vasculitis
The pivotal ADVOCATE trial showed that, relative to prednisone, the oral C5a receptor antagonist yielded a superior rate of sustained remission at...
Conference Coverage
Study tests a simpler low disease activity measure for lupus
An index that includes continuous scoring and more disease manifestations is simpler than the Lupus Low Disease Activity Scale and performs...